Oramed Pharmaceuticals Cash Flow Statement (2010-2026) | ORMP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-22.99M-11.65M-12.10M-7.25M-12.05M-3.62M-1.31M-3.28M13.30M1.53M9.20M-19.64M-10.20M-7.64M13.26M48.39M21.20M38.31M
Depreciation and Depletion (Quarter)
0.03M0.07M0.01M0.01M0.01M0.01M0.02M0.04M0.05M0.05M0.05M0.06M0.05M0.05M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based Compensation (Quarter)
0.98M2.66M1.71M0.68M1.88M2.86M-8.18M0.17M-1.77M-0.80M1.37M1.28M1.21M0.29M1.22M2.19M0.80M0.72M1.44M1.74M
Deferred Taxes (Quarter)
-7.69M0.01M-9.84M
Gains from Investment Securities (Quarter)
0.27M-0.07M-0.76M0.63M-16.20M-3.75M-12.97M16.58M7.55M3.35M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-5.64M-11.20M-6.90M-9.12M-8.49M-2.24M-8.06M-5.55M-2.63M-0.69M-1.42M-1.48M2.08M-7.10M-1.91M-3.52M-3.54M-1.62M-0.47M-2.92M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.03M0.07M0.01M0.01M0.01M0.01M0.02M0.04M0.05M0.05M0.05M0.06M0.05M0.05M0.03M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Account Payables (Quarter)
-0.10M-3.23M1.73M-0.62M-0.67M2.21M1.55M
Change in Accured Expenses (Quarter)
-0.02M0.08M-0.00M0.00M0.01M0.00M-2.23M-0.67M2.21M-1.55M3.52M-0.06M0.15M
Other Working Capital Changes (Quarter)
-0.07M-0.07M-0.02M-0.01M-1.31M0.00M0.00M0.02M0.01M0.00M-2.00M2.12M-2.00M
Investing Activities
Capital Expenditures (Quarter)
0.00M0.37M0.05M0.02M0.12M0.31M0.20M0.02M0.03M0.00M0.00M0.01M0.01M0.00M0.00M0.00M0.01M
Divestments (Quarter)
2.74M0.71M2.81M
Change in Acquisitions & Divestments (Quarter)
1.05M5.91M0.95M5.00M-1.21M124.21M50.20M4.50M-1.77M0.65M15.00M20.00M2.00M60.15M28.45M-27.40M49.40M-47.59M3.52M
Cash from Investing Activities (Quarter)
7.39M-17.43M-99.05M7.36M10.36M1.23M11.26M-13.20M-14.71M-75.12M30.00M30.00M94.66M-34.26M15.42M23.62M-54.85M38.36M-1.68M-19.49M
Financing Activities
Other financing activities (Quarter)
0.02M0.50M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
74.55M19.00M30.55M69.20M65.48M
Change in Capital Stock
Shares Issued (Quarter)
0.86M2.04M0.09M1.91M1.06M1.44M0.28M
Net Equity Issued and Repurchased (Quarter)
10.62M10.62M-7.65M4.38M4.16M2.43M-0.00M
Dividend Payments
Dividends Paid - Common (Quarter)
10.36M
Misc.
Cash from Financing Activities (Quarter)
21.86M80.58M60.56M2.29M-0.00M4.31M4.17M2.43M74.55M-25.00M-19.00M-30.55M-1.29M-1.20M-0.36M-4.01M-10.36M
Exchange Rate Effect (Quarter)
-0.00M-0.00M0.02M0.01M0.00M-0.10M-0.04M0.01M-0.03M0.01M-0.00M-0.00M0.00M-0.00M-0.00M0.04M0.00M-0.07M0.02M
Change in Cash (Quarter)
23.61M51.97M-45.37M0.51M1.93M3.30M7.27M-16.36M-17.34M-1.30M3.59M9.52M66.18M-42.65M12.32M20.10M-58.72M36.38M-6.23M-32.74M
Free Cash Flow (Quarter)
-5.64M-11.57M-6.90M-9.17M-8.51M-2.36M-8.37M-5.75M-2.65M-0.73M-1.42M-1.48M2.08M-7.11M-1.92M-3.52M-3.54M-1.62M-0.47M-2.92M
Net Cash Flow (Quarter)
23.61M51.96M-45.39M0.53M1.87M3.30M7.37M-16.32M-17.34M-1.27M3.58M9.52M66.18M-42.65M12.32M20.10M-58.39M36.38M-6.16M-32.77M